Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV)
poses a challenge for public health laboratories as virus isolates are unavailable while there …

In late December 2019, a cluster of cases of pneumonia of unknown etiology were reported
linked to a market in Wuhan, China 1 . The causative agent was identified as the species …

Animal experiments have shown that nonhuman primates, cats, ferrets, hamsters, rabbits,
and bats can be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …

Key questions in COVID-19 are the duration and determinants of infectious virus shedding.
Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 …

The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …

SARS-CoV-2 has been identified as the causative agent of a global outbreak of respiratory
tract disease (COVID-19). In some patients, the infection results in moderate to severe acute …

The final months of 2019 witnessed the emergence of a novel coronavirus in the human
population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread …

The emergence and rapid spread of SARS-CoV-2 variants may affect vaccine efficacy
substantially. The Omicron variant termed BA.2, which differs substantially from BA.1 based on …

Background 10 days after the first reported case of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in the Netherlands (on Feb 27, 2020), 55 (4%) of 1497 …

Background Long-term shedding of viral RNA in COVID-19 prevents timely discharge from
the hospital or de-escalation of infection prevention and control practices. Key questions are …